A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic Impairment

Update Il y a 4 ans
Reference: NCT01257178

Woman and Man

Extract

The purpose of this study is to evaluate the impact of hepatic dysfunction on the pharmacokinetics and safety of LY2624803 and its major metabolite, LSN2797276.


Inclusion criteria

  • Insomnia

Links